Ï㽶ÊÓƵ

Dr. Azoulay’s research program is in cancer pharmacoepidemiology. This program aims to provide much needed information on the long-term effects of commonly-prescribed drugs on the incidence of cancer, as well as to assess the safety of cancer treatments in the real-world setting. Over the years, Dr. Azoulay developed a strong interest on the potential effects of anti-diabetic drugs on the development of cancer. With respect to the safety of cancer treatments, he has been particularly interested in the pleiotropic effects of androgen deprivation therapy, a common treatment used in advanced prostate cancer.